Is NCT03200080 results overdue?

Yes — results are overdue. Primary completion was 2017-11-28; the FDAAA-801 reporting deadline (2018-11-28) passed 2762 days ago and no results are posted on ClinicalTrials.gov.

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

NCT ID	NCT03200080 ↗
Sponsor	Biotie Therapies Inc. (INDUSTRY)
Phase	PHASE1
Status	TERMINATED
Primary completion	2017-11-28 (ACTUAL)
Reporting deadline	2018-11-28 (completion + 365d)
Days overdue	2762
Results posted	No — check results tab ↗
FDA-regulated	drug: yes, device: no
Provenance	Flagged overdue on 2026-06-21 · SHA-256 `dd590e5378689383…` (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03200080. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.